Flash FinanceUS
Market closed S&P 5007,549.94+2.35% Nasdaq25,253.14+2.74% Dow 3052,389.75+2.15% Russell 20002,840.81+3.15% Nasdaq-10027,907.62+3.40% MidCap 4003,715.23+3.13% SmallCap 6001,722.37+2.89% VIX19.92-22.31% 10Y Yield4.86+0.10% Close of Nov 09, 2026
AI brief of an SEC Form 8-K · Gilead Sciences (GILD)

Gilead Sciences says General Counsel Deborah Telman leaves role December 5, 2025

Neutral Impact 4 of 5 leadership Written later

Gilead Sciences disclosed that Deborah H. Telman will no longer serve as Executive Vice President, Corporate Affairs and General Counsel effective December 5, 2025, with her employment ending later in the month. The filing does not give a reason for the departure or name a successor, so shareholders have no information yet on how the change will affect the company's legal and corporate affairs functions.

Key points

  • Deborah H. Telman leaves the role of Executive Vice President, Corporate Affairs and General Counsel effective December 5, 2025.
  • Her employment with the company will terminate later in November 2025, according to the filing.
  • The filing does not name a successor or state the reason for the departure.

The filing

CompanyGilead Sciences (GILD)
Form8-K, current report
Filed with the SECNov 19, 2025, 8:30 AM ET
Accession number0001104659-25-113968

Items reported: 5.02 Director / Officer Change

Read the filing on SEC.gov ↗

Written by AI on Nov 8, 2026, 2:16 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on November 19, 2025.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.